Clinical Trial Update: Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial comparing Vacc-4x plus lenalidomide versus Vacc-4x plus placebo in HIV-1-infected individuals on ART has completed and results were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Lenalidomide (lenalidomide)
• Vacc-4x

Snippet

Sponsor: Bionor Immuno AS | Conditions: HIV-1 Infection | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-03-08